CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,778 enrolled
Drug / intervention
Behavioral questionairesbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05212883
NCT05212883N/ACompleted
CompareCT.gov

Rapid Acceleration for Diagnostics in Underserved Populations: Home Testing

Duke University·observational·Posted Jan 28, 2022·Updated Jun 6, 2023

In Brief

An observational study evaluating Behavioral questionaires for COVID-19. Completed, enrolled 2,778 participants across 1 site.

Detailed Summary

Observational, study that distributes rapid at-home, self-administered, SARS-CoV-2 antigen testing kits to households within pre-selected communities.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID-19
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), National Institute on Minority Health and Health Disparities (NIMHD)

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJan 28, 2022
Enrollment StartNov 15, 2021
Primary CompletionMar 8, 2022
Study CompletionApr 19, 2022
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 4.4 years ago

Interventions

Behavioral questionairesbehavioral

Behavioral surveys and questionnaires